Insider Selling: Ryan Specialty Holdings, Inc. (NYSE:RYAN) Director Sells 35,000 Shares of Stock
by Danessa Lincoln · The Markets DailyRyan Specialty Holdings, Inc. (NYSE:RYAN – Get Free Report) Director Nicholas Dominic Cortezi sold 35,000 shares of the business’s stock in a transaction on Wednesday, December 18th. The stock was sold at an average price of $65.17, for a total transaction of $2,280,950.00. Following the completion of the sale, the director now owns 50,400 shares of the company’s stock, valued at $3,284,568. The trade was a 40.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.
Nicholas Dominic Cortezi also recently made the following trade(s):
- On Friday, December 20th, Nicholas Dominic Cortezi sold 91 shares of Ryan Specialty stock. The shares were sold at an average price of $65.00, for a total transaction of $5,915.00.
- On Monday, December 16th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $66.71, for a total value of $2,334,850.00.
- On Friday, December 13th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The shares were sold at an average price of $67.39, for a total value of $2,358,650.00.
Ryan Specialty Price Performance
Shares of RYAN stock traded down $0.49 during trading hours on Monday, hitting $63.52. 109,862 shares of the company’s stock were exchanged, compared to its average volume of 874,911. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. The stock has a market cap of $16.63 billion, a price-to-earnings ratio of 82.49, a price-to-earnings-growth ratio of 1.52 and a beta of 0.67. The stock’s 50-day moving average is $70.23 and its 200-day moving average is $64.80. Ryan Specialty Holdings, Inc. has a 52 week low of $41.65 and a 52 week high of $75.97.
Ryan Specialty (NYSE:RYAN – Get Free Report) last released its earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.41. The company had revenue of $604.69 million during the quarter, compared to the consensus estimate of $602.04 million. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The firm’s quarterly revenue was up 20.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.32 earnings per share. As a group, research analysts forecast that Ryan Specialty Holdings, Inc. will post 1.82 EPS for the current year.
Ryan Specialty Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Tuesday, November 12th were paid a dividend of $0.11 per share. This represents a $0.44 dividend on an annualized basis and a dividend yield of 0.69%. The ex-dividend date of this dividend was Tuesday, November 12th. Ryan Specialty’s dividend payout ratio (DPR) is 57.14%.
Hedge Funds Weigh In On Ryan Specialty
Large investors have recently bought and sold shares of the business. Louisiana State Employees Retirement System bought a new position in Ryan Specialty during the 2nd quarter worth approximately $1,668,000. Retirement Systems of Alabama bought a new stake in shares of Ryan Specialty in the 2nd quarter valued at $7,316,000. Bank of New York Mellon Corp lifted its holdings in Ryan Specialty by 132.2% during the second quarter. Bank of New York Mellon Corp now owns 836,209 shares of the company’s stock worth $48,425,000 after acquiring an additional 476,126 shares in the last quarter. State of Michigan Retirement System bought a new stake in shares of Ryan Specialty in the second quarter worth about $1,621,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of Ryan Specialty by 14.4% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 23,069 shares of the company’s stock worth $1,336,000 after purchasing an additional 2,909 shares during the period. 84.82% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several analysts have issued reports on RYAN shares. Wells Fargo & Company raised their price target on shares of Ryan Specialty from $63.00 to $70.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 10th. Barclays raised their target price on Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a research report on Thursday, November 21st. Bank of America boosted their price target on shares of Ryan Specialty from $75.00 to $84.00 and gave the company a “buy” rating in a report on Thursday, October 10th. BMO Capital Markets raised shares of Ryan Specialty from a “market perform” rating to an “outperform” rating and raised their price objective for the stock from $65.00 to $75.00 in a report on Tuesday, September 24th. Finally, The Goldman Sachs Group increased their price target on shares of Ryan Specialty from $64.00 to $72.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 9th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, Ryan Specialty presently has a consensus rating of “Hold” and an average target price of $73.50.
Read Our Latest Analysis on RYAN
Ryan Specialty Company Profile
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Featured Stories
- Five stocks we like better than Ryan Specialty
- What is Put Option Volume?
- Time to Board Carnival Cruise Lines’ Stock Price Rally
- ESG Stocks, What Investors Should Know
- Is Warner Bros. Discovery Stock a Buy After Recent Drop?
- How to Invest in the Best Canadian Stocks
- Industrial Chemicals: 3 Stocks Poised for Growth in the New Year